Flagship Pioneering Inc. Foghorn Therapeutics Inc. Transaction History
Flagship Pioneering Inc.
- $837 Million
- Q2 2024
A detailed history of Flagship Pioneering Inc. transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Flagship Pioneering Inc. holds 12,674,120 shares of FHTX stock, worth $102 Million. This represents 8.71% of its overall portfolio holdings.
Number of Shares
12,674,120
Previous 12,674,120
-0.0%
Holding current value
$102 Million
Previous $85 Million
14.31%
% of portfolio
8.71%
Previous 5.6%
Shares
1 transactions
Others Institutions Holding FHTX
# of Institutions
72Shares Held
32.7MCall Options Held
6KPut Options Held
1.8K-
Bvf Inc San Francisco, CA5.3MShares$42.8 Million0.93% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.52MShares$20.3 Million0.3% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$18.5 Million0.01% of portfolio
-
Euclidean Capital LLC New York, NY1.57MShares$12.7 Million1.14% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$12.5 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $336M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...